Berlin, 25.02.2025

As of the first of February, Achim Geppert has joined the Lucid Genomics team as a Co-Founder and Chief Commercial Officer. As CCO, Achim will be responsible for shaping the business development and commercial strategy of our platform. He will strengthen Lucid Genomics’ position as a provider of whole genome sequencing analysis.

With his more than 8 years experience in consultancy, he gained substantial knowledge on the life sciences field. Putting his efforts in to high numbers of projects related to MedTech and Digital Health, his interest in the field grew. Achim will now use this to drive our growth story, to help unlock the full potential of the genome.

Achim on joining Lucid Genomics: “Lucid Genomics is at the forefront of leveraging whole genome sequencing for drug discovery and development. I’m excited to shape the commercial strategy and bring this game-changing technology to the right partners. Let’s make an impact together!”